StockData
AMSNYSEServices-Medical LaboratoriesFiscal year ends December 31

AMERICAN SHARED HOSPITAL SERVICES

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$1.26−0.02 (-1.20%)

Close on Oct 19, 2026

Market cap
$8.69M
P/E (TTM)
–
Dividend yield
–

About American Shared Hospital Services

Services-Medical Laboratories, SIC 8071

American Shared Hospital Services provides equipment and solutions for stereotactic radiosurgery and advanced radiation therapy. The company operates through two segments: medical equipment leasing and direct patient services. Through its leasing segment, it supplies medical equipment such as Gamma Knife units and proton beam radiation therapy systems to healthcare facilities under fee-per-use or revenue-sharing agreements. Through its direct patient services segment, the company operates treatment facilities that provide care directly to individuals. Its primary customers include hospitals, medical centers, cancer clinics, and cancer patients.

The company operates across the United States, Peru, Ecuador, and Mexico. In the United States, it provides Gamma Knife systems to seven medical centers across eight states, maintains a proton beam radiation therapy system in Florida, and operates three radiation therapy cancer centers in Rhode Island. Internationally, the company operates standalone Gamma Knife facilities in Lima, Peru and Guayaquil, Ecuador, as well as a radiation therapy facility in Puebla, Mexico. The company was incorporated in California.

Summary of the business section of American Shared Hospital Services's latest annual report, written by StockData.

Company profile

Company

Legal name
AMERICAN SHARED HOSPITAL SERVICES
Founded
1980
Headquarters
San Francisco, CA
Address
601 Montgomery Street, Suite 1112 94111
Phone
(415) 788-5300
Employees
44, Dec 31, 2025
Industry
Services-Medical Laboratories
Incorporated in
California
Fiscal year ends
December 31
Auditor
Baker Tilly US, LLP, San Francisco, CA

Stock & identifiers

Ticker
AMS
Exchange
NYSE
Shares outstanding
7M, Aug 11, 2026
Public float
$11.89M, Jun 30, 2025
Filer category
Non-accelerated filer<br>Smaller reporting company
SEC CIK
744825
CUSIP
029595105
ISIN
US0295951059
EIN
94-2918118

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Raymond C. StachowiakExecutive Chairman, Director2,280,205
Alexis TirritoInterim CFO, CAO and Secretary9,634
Craig Kenji TagawaPresident35,501
Raymond Scott FrechChief Financial Officer50,000
Gary DelanoisChief Operating Officer120,000

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025
Raymond C. Stachowiak
$526.40K$523.25K$385.94K$71–
FY2024
Raymond C. Stachowiak
$603.29K$666.59K$464.56K$132–
FY2023
Raymond C. Stachowiak
$626.60K$588.50K$395.00K$81–
FY2022$560.00K$574.40K$323.61K$122–

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Employees

Headcount reported in annual reports

“At December 31, 2025, the Company had a workforce of 44 people on a full-time basis, three on a per diem basis, and two part-time in the United States, 16 people on a full-time basis in Lima, Peru, three people on a full-time basis in Guayaquil, Ecuador, and 19 people on a full-time basis in Puebla, Mexico.”

Corporate history

Events identified from SEC filings